LEVITRA (vardenafil hydrochloride) is directed orally for the treatment of erectile brokenness. This monohydrochloride salt of vardenafil is a particular inhibitor of cyclic guanosine monophosphate (cGMP)- particular phosphodiesterase type 5 (PDE5).
Vardenafil HCl is assigned artificially as piperazine, 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)- 4-ethoxyphenyl]sulfonyl]-4-ethyl-, monohydrochloride and has the accompanying auxiliary equation:
LEVITRA (vardenafil hydrochloride) Structural Formula Illustration
Vardenafil HCl is an about drab, strong substance with an atomic weight of 579.1 g/mol and a solvency of 0.11 mg/mL in water.
LEVITRA is figured as orange, round, film-covered tablets with “BAYER” cross debossed on one side and “2.5”, “5”, “10”, and “20” on the opposite side comparing to 2.5 mg, 5 mg, 10 mg, and 20 mg of vardenafil, individually. Notwithstanding the dynamic fixing, vardenafil HCl, every tablet contains microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, yellow ferric oxide, and red ferric oxide.